Huang Junjie signed share transfer agreement to acquire 5.03% stake in Guangdong Jiaying Pharmaceutical Co., Ltd (SZSE:002198) from Liu Libiao for CNY 230 million on June 17, 2024. A cash consideration of CNY 234.65 million valued at CNY 9.2 per share will be paid by the buyer. As part of consideration, CNY 234.65 million is paid towards common equity of Guangdong Jiaying Pharmaceutical Co., Ltd. The transaction is subject to approval by regulatory board / committee.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6.69 CNY | +0.90% |
|
-15.95% | -8.10% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-8.10% | 464M | |
+13.97% | 4.95B | |
-32.08% | 3.6B | |
-1.63% | 3.03B | |
-24.62% | 2.66B | |
-9.82% | 2.34B | |
+38.87% | 1.85B | |
+38.84% | 1.45B | |
-15.47% | 1.41B | |
+40.95% | 1.38B |
- Stock Market
- Equities
- 002198 Stock
- News Guangdong Jiaying Pharmaceutical Co., Ltd
- Huang Junjie signed share transfer agreement to acquire 5.03% stake in Guangdong Jiaying Pharmaceutical Co., Ltd from Liu Libiao for CNY 230 million.